- Tytuł:
- METTL3 and METTL14-mediated N -methyladenosine modification of SREBF2-AS1 facilitates hepatocellular carcinoma progression and sorafenib resistance through DNA demethylation of SREBF2.
- Autorzy:
- Źródło:
- Scientific reports [Sci Rep] 2024 Mar 14; Vol. 14 (1), pp. 6155. Date of Electronic Publication: 2024 Mar 14.
- Typ publikacji:
- Journal Article
- MeSH Terms:
-
Carcinoma, Hepatocellular*/drug therapy
Carcinoma, Hepatocellular*/genetics
Carcinoma, Hepatocellular*/metabolism
Liver Neoplasms*/drug therapy
Liver Neoplasms*/genetics
Liver Neoplasms*/metabolism
MicroRNAs*/geneticsSterol Regulatory Element Binding Protein 2*
Adenosine/*analogs & derivatives
Humans ; Sorafenib/pharmacology ; DNA Demethylation ; Cell Line, Tumor ; RNA-Binding Proteins/metabolism ; Mixed Function Oxygenases/metabolism ; Proto-Oncogene Proteins/metabolism ; Methyltransferases/genetics ; Methyltransferases/metabolism
Czasopismo naukowe